Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vitro Biopharma, Inc To Start Trading Tomorrow

Vitro Biopharma, Inc (NASDAQ:VTRO) IPO will take place September, 13 on the NASDAQ exchange under the ticker VTRO.…
byBenzinga Insights
September 12, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vitro Biopharma, Inc (NASDAQ:VTRO) IPO will take place September, 13 on the NASDAQ exchange under the ticker VTRO.

The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on March 11, 2024.

See also: Benzinga IPO Calendar

About Vitro Biopharma, Inc

Vitro Biopharma, Inc is an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. With respect to our regenerative medicine business

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GM-Backed Self-Driving Company Momenta Readies For US IPO Launch: Report

By Shivani Kumaresan
May 6, 6:46 AM
Auto giant General Motors-backed Beijing Momenta Technology Co., a Chinese self-driving firm, has quietly filed for a potential IPO in the U.S., report says. Momenta reportedly aims to raise $200-$300 million through share sales, with discussions ongoing. The move underscores Momenta's rapid growth and signifies a significant step in its global expansion strategy.

GM